Natera, Inc. (NTRA)
321.96
-4.30
(-1.32%)
USD |
NASDAQ |
Aug 31, 16:00
319.09
-2.87
(-0.89%)
After-Hours: 06:05
Natera Free Cash Flow : 51.20M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 51.20M |
| March 31, 2026 | 71.51M |
| December 31, 2025 | 76.11M |
| September 30, 2025 | 93.56M |
| June 30, 2025 | 94.06M |
| March 31, 2025 | 74.70M |
| December 31, 2024 | 58.75M |
| September 30, 2024 | -43.68M |
| June 30, 2024 | -107.32M |
| March 31, 2024 | -186.98M |
| December 31, 2023 | -286.15M |
| September 30, 2023 | -311.45M |
| June 30, 2023 | -387.25M |
| March 31, 2023 | -418.52M |
| December 31, 2022 | -479.20M |
| September 30, 2022 | -493.98M |
| June 30, 2022 | -483.72M |
| March 31, 2022 | -444.29M |
| December 31, 2021 | -376.27M |
| September 30, 2021 | -349.36M |
| June 30, 2021 | -280.24M |
| March 31, 2021 | -244.24M |
| Date | Value |
|---|---|
| December 31, 2020 | -202.12M |
| September 30, 2020 | -138.75M |
| June 30, 2020 | -117.27M |
| March 31, 2020 | -78.66M |
| December 31, 2019 | -68.41M |
| September 30, 2019 | -65.87M |
| June 30, 2019 | -76.09M |
| March 31, 2019 | -107.43M |
| December 31, 2018 | -74.46M |
| September 30, 2018 | -88.39M |
| June 30, 2018 | -96.96M |
| March 31, 2018 | -76.54M |
| December 31, 2017 | -107.69M |
| September 30, 2017 | -116.99M |
| June 30, 2017 | -116.18M |
| March 31, 2017 | -125.21M |
| December 31, 2016 | -97.19M |
| September 30, 2016 | -65.16M |
| June 30, 2016 | -51.24M |
| March 31, 2016 | -42.14M |
| December 31, 2015 | -45.41M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Guardant Health, Inc. | -228.54M |
| CareDx, Inc. | 84.03M |
| Myriad Genetics, Inc. | -14.20M |
| BioRestorative Therapies, Inc. | -11.90M |
| Exagen, Inc. | -7.588M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 54.79M |
| Cash from Investing (Quarterly) | -63.43M |
| Cash from Financing (Quarterly) | 12.21M |
| Free Cash Flow Per Share (Quarterly) | -0.0603 |
| Free Cash Flow to Equity (Quarterly) | -7.043M |
| Free Cash Flow to Firm (Quarterly) | -7.750M |
| Free Cash Flow Yield | 0.11% |